Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bio-Techne (TECH)
NASDAQ:TECH
Bio-Techne (TECH) Stock Price & Analysis
412 Followers
TECH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$51.61 - $89.50
Previous Close$82.5
Volume364.97K
Average Volume (3M)1.13M
Market Cap
$13.09B
Enterprise Value$13.42B
Total Cash (Recent Filing)$135.65M
Total Debt (Recent Filing)$555.70M
Price to Earnings (P/E)65.6
Beta1.19
Next Earnings
Aug 06, 2024EPS Estimate
$0.5Last Dividend Ex-Date
May 10, 2024Dividend Yield0.38%
Share Statistics
EPS (TTM)1.26
Shares Outstanding157,584,637
10 Day Avg. Volume1,139,673
30 Day Avg. Volume1,129,502
Standard Deviation0.10
R-Squared0.44
Alpha-0.00403
Financial Highlights & Ratios
Price to Book (P/B)30.51
Price to Sales (P/S)11.44
Price to Cash Flow (P/CF)39.70
P/FCF Ratio46.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.72
Enterprise Value/Gross Profit17.43
Enterprise Value/Ebitda35.55
Forecast
1Y Price Target
$81.63Price Target Upside-1.76% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Bio-Techne News
PremiumPress Releases
BIO-TECHNE DECLARES DIVIDEND
PremiumCompany Announcements
Bio-Techne Board Expansion and Strategic Director Appointments
Bulls Say, Bears Say
Bulls Say
Market RecoveryConsumables likely to recover first as biopharma funding recovery and China stabilization are observed.
Revenue StreamsRecurring revenue streams from companies like TECH, RVTY, and BIO are expected to benefit early from the biopharma sector's recovery.
Strategic InvestmentsInvestments in local China capacities are strategic moves to leverage long-term market recovery and opportunities.
Bears Say
EarningsOrganic growth fell short of the expected guidance.
ProfitabilityGross margin percentage experienced a significant decline year-over-year.
Sector PerformanceLife Science Tools sector faced revenue declines due to market headwinds.
---
Ownership Overview
2.27% Insiders
42.76% Mutual Funds
52.03% Other Institutional Investors
2.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TECH FAQ
What was Bio-Techne’s price range in the past 12 months?
Bio-Techne lowest stock price was $51.60 and its highest was $89.50 in the past 12 months.
What is Bio-Techne’s market cap?
Currently, no data Available
When is Bio-Techne’s upcoming earnings report date?
Bio-Techne’s upcoming earnings report date is Aug 06, 2024 which is in 77 days.
How were Bio-Techne’s earnings last quarter?
Bio-Techne released its earnings results on May 01, 2024. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.453 by $0.027.
Is Bio-Techne overvalued?
According to Wall Street analysts Bio-Techne’s price is currently Overvalued.
Does Bio-Techne pay dividends?
Bio-Techne pays a Quarterly dividend of $0.08 which represents an annual dividend yield of 0.38%. See more information on Bio-Techne dividends here
What is Bio-Techne’s EPS estimate?
Bio-Techne’s EPS estimate is $0.5.
How many shares outstanding does Bio-Techne have?
Bio-Techne has 157,584,640 shares outstanding.
What happened to Bio-Techne’s price movement after its last earnings report?
Bio-Techne reported an EPS of $0.48 in its last earnings report, beating expectations of $0.453. Following the earnings report the stock price went up 16.215%.
Which hedge fund is a major shareholder of Bio-Techne?
Among the largest hedge funds holding Bio-Techne’s share is Mairs & Power Inc. It holds Bio-Techne’s shares valued at 208M.
---
Bio-Techne Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$81.63 (-1.76% Downside)
$81.63 (-1.76% Downside)
Blogger Sentiment
Bullish
TECH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 9.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 3.5%
Last 30 Days ▲ 3.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.19%
12-Months-Change
Fundamentals
Return on Equity
10.40%
Trailing 12-Months
Asset Growth
4.67%
Trailing 12-Months
Company Description
Bio-Techne
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community. The Protein Platforms segment develops, manufactures, and sells tools to simplify protein analysis. The Diagnostics segment includes blood chemistry and blood gas quality controls, hematology instrument controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market worldwide. The company was founded on 1976 and is headquartered in Minneapolis, MN.
---
TECH Earnings Call
Q3 2024
0:00 / 0:00
---
TECH Net revenue Breakdown
74.40% Protein Sciences
25.74% Diagnostics and Genomics
---
TECH Stock 12 Month Forecast
Average Price Target
$81.63
▼(-1.76% Downside)
Technical Analysis
Best Analysts Covering TECH
1 Year
1 Year Success Rate
19/31 ratings generated profit
1 Year Average Return
+16.45%
reiterated a buy rating 21 days ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 61.29% of your transactions generating a profit, with an average return of +16.45% per trade.
---